Technical Data
R1600-13
Respiratory Syncytial Virus (RSV)
Description:
RSV is so named from the formation of syncytia, or multinucleated masses of fused cells. Two virally specified surface glycoproteins are prominent in RSV. The large glycoprotein is designated G and the other fusion protein is designated F. In addition, two distinct groups may be present in RSV, Group A and/or Group B.

Applications:
Suitable for use in ELISA, Fusion Inhibition, and Immunofluorescence. Excellent for soild phase application. Other applications not tested.

Recommended Dilutions:
ELISA: 1:10,000
Fusion Inhibition: > 1:256
IFA: 1:480
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGPurified
SizeStorageShippingSourceHost
1mg-20°CBlue IceGoat
Concentration:
~5mg/ml
Immunogen:
Human RSV isolate, confirmed.
Purity:
Purified
Form
Supplied as a liquid in PBS, pH 7.2., 0.1% sodium azide.
Specificity:
Recognizes human Respiratory Syncytial Virus. No reaction with Influenza A & B, Para 1-3 and Adenovirus by IFA. Uninfected cell reactivity: Negative vs. WI-38 cells or HEp-2.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.